| Literature DB >> 32059508 |
Camila Dantas Malossi1, Eduardo Gorzoni Fioratti2, Jedson Ferreira Cardoso3, Angelo Jose Magro1, Erna Geessien Kroon4, Daniel de Moura Aguiar5, Alice Mamede Costa Marque Borges5, Marcia Furlan Nogueira6, Leila Sabrina Ullmann1, João Pessoa Araujo1.
Abstract
Equine infectious anemia virus (EIAV) is a persistent lentivirus that causes equine infectious anemia (EIA). In Brazil, EIAV is endemic in the Pantanal region, and euthanasia is not mandatory in this area. All of the complete genomic sequences from field viruses are from North America, Asia, and Europe, and only proviral genomic sequences are available. Sequences from Brazilian EIAV are currently available only for gag and LTR regions. Thus, the present study aimed for the first time to sequence the entire EIAV genomic RNA in naturally infected horses from an endemic area in Brazil. RNA in plasma from naturally infected horses was used for next-generation sequencing (NGS), and gaps were filled using Sanger sequencing methodology. Complete viral genomes of EIAV from two horses were obtained and annotated (Access Number: MN560970 and MN560971). Putative genes were analyzed and compared with previously described genes, showing conservation in gag and pol genes and high variations in LTR and env sequences. Amino acid changes were identified in the p26 protein, one of the most common targets used for diagnosis, and p26 molecular modelling showed surface amino acid alterations in some epitopes. Brazilian genome sequences presented 88.6% nucleotide identity with one another and 75.8 to 77.3% with main field strains, such as EIAV Liaoning, Wyoming, Ireland, and Italy isolates. Furthermore, phylogenetic analysis suggested that this Brazilian strain comprises a separate monophyletic group. These results may help to better characterize EIAV and to overcome the challenges of diagnosing and controlling EIA in endemic regions.Entities:
Keywords: RNA genome; endemic region; equine; equine infectious anemia virus; molecular characterization
Mesh:
Substances:
Year: 2020 PMID: 32059508 PMCID: PMC7077297 DOI: 10.3390/v12020207
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Primers for equine infectious anemia virus (EIAV) genome regions. Genome positions are according to MN560970.
| Primer | Sequence 5′-3′ | Genome Position | Product Size |
|---|---|---|---|
| AIE_GEN F 463-482 | CCA GAG CAC AGG ARG ACA GG | 463-482 | |
| AIE_GEN R 926-906 * | CCT CTG GGK GTT AAG GGT CGG | 926-906 | 889 bp |
| AIE_GEN R 1352-1333 | TAA GGC TCT TTK GGS CCT TG | 1352-1333 | |
| AIE_GEN F 1333-1352 | CAA GGS CCM AAA GAG CCT TA | 1333-1352 | |
| AIE_GEN R 1963-1943 * | TTA CTC CCA CAA ACT GCT CAG | 1963-1943 | 940 bp |
| AIE_GEN R 2273-2254 | GCC ATT ACC AAT TGT GCC CC | 2273-2254 | |
| AIE_GEN F 3878-3897 | GCC AGG TCA CAA GGG CAT AT | 3878-3897 | |
| AIE_GEN R 4540-4521 * | CCT GCA GGT CCA GAT CCY TG | 4540-4521 | 1096 bp |
| AIE_GEN R 4974-4955 | CCA TGG TGT TTG KCC YCC CA | 4974-4955 | |
| AIE_GEN F 5112-5132 | GGG TGA TGG TGC TGT AGT GGT | 5112-5132 | |
| AIE_GEN F 5934-5959 * | GTG TAC AGA TAG TGA TCA TTG TCA AG | 5934-5959 | 1637 bp |
| AIE_GEN R 6749-6727 | GCC CGA GAA GTA ACA GGA AAA GG | 6749-6727 | |
| AIE_GEN F 6823-6842 | GCT ATT GCT GCT AGT GCY AC | 6823-6842 | 1177 bp |
| AIE_GEN R 8000-7981 | AGA TGT AGC TGG ATT TAR CG | 8000-7981 | |
| AIE_GEN F 7751-7770 | CAA AGC GAA GGA GGA AAC AT | 7751-7770 | 526 bp |
| AIE_GEN R 8277-8258 | GGG ACT CAG ACC GCA GAA TC | 8277-8258 |
* Used as an inner primer for Sanger sequencing.
Summary statistics for the two equine infectious anemia virus sequenced genomes.
| Samples | Raw Reads | Reads at Least Q30 | Mapped Reads | Mean Coverage |
|---|---|---|---|---|
| BRA1 | 18,371,626 | 92.7% | 422,676 | 3969 |
| BRA2 | 10,374,696 | 71.2% | 6927 | 78.3 |
The identity matrix with EIAV genomes shows the percentage of bases/residues that are identical.
| Miyazaki | BRA1 | BRA2 | Cornwall | Wyoming | Devon | Liaoning | IRE H3 | IRE F4 | IRE F2 | IRE F3 | ITA SA | ITA DE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Miyazaki - JX003263 | |||||||||||||
| BRA1 - MN560970 | 74.963 | ||||||||||||
| BRA2 - MN560971 | 74.944 | 88.507 | |||||||||||
| Cornwall 2012 - MH580898 | 72.507 | 75.171 | 75.440 | ||||||||||
| Wyoming - AF033820 | 75.156 | 76.601 | 76.614 | 74.829 | |||||||||
| Devon 2010 - MH580897 | 75.897 | 76.500 | 77.322 | 75.255 | 77.490 | ||||||||
| Liaoning - AF327877 | 76.531 | 76.751 | 77.491 | 75.115 | 77.860 | 78.906 | |||||||
| IRE H3 - JX480634 | 75.568 | 77.021 | 76.741 | 75.044 | 78.189 | 78.855 | 79.018 | ||||||
| IRE F4 - JX480633 | 75.520 | 77.058 | 76.741 | 74.994 | 78.196 | 78.951 | 79.066 | 99.190 | |||||
| IRE F2 - JX480631 | 75.348 | 77.042 | 77.015 | 75.224 | 78.393 | 79.080 | 79.297 | 98.937 | 99.118 | ||||
| IRE F3 - JX480632 | 75.612 | 77.005 | 76.741 | 75.053 | 78.149 | 78.934 | 78.990 | 99.057 | 99.299 | 99.420 | |||
| ITA SA - KM247555 | 75.455 | 76.756 | 76.823 | 75.409 | 78.338 | 79.128 | 79.252 | 98.512 | 98.792 | 99.197 | 98.983 | ||
| ITA DE - KM247554 | 75.253 | 76.630 | 76.798 | 75.282 | 78.288 | 79.014 | 79.176 | 98.461 | 98.665 | 99.133 | 98.944 | 99.324 |
Figure 1Cladogram involving equine infectious anemia virus (EIAV) complete genome sequences and BRA1 and BRA2 sequences obtained from the Pantanal region using the maximum-likelihood method. The following sequences were used: EIAV Miyazaki 2011A (Japan); EIAV BRA1 and EIAV BRA2 (Brazil); EIAV Liaoning (China); EIAV Wyoming (USA); EIAV ITA SA and EIAV ITA DE (Italy); EIAV IRE F2, EIAV IRE F3, EIAV IRE F4 and EIAV IRE H3 (Ireland); EIAV Cornwall 2012 and EIAV Devon 2010 (England); bovine Immunodeficiency virus (outgroup—NC_001413.1).
Figure 2Representative genome of EIAV BRA1. Genome annotation shows the variant distribution, marked below in yellow. Coverage is represented in blue, and identity is represented in dark yellow.
Previously described epitope alterations for each p26 sequence obtained. Alterations are marked in red.
| Reference | Epitope | BRA1 | BRA2 |
|---|---|---|---|
| [ | 73NLDKIAEE80 | 73 | 73 |
| [ | 199KNAMRHLRPEDTLEEKMYAC218 | 199 | 199KNAMRHLRPEDTLEEK |
| [ | 158KEPYPEFVDRLLSQI172 | 158KEPYPEFVDRLLSQI172 | 158KEPYPEFVDRLLSQI172 |
| [ | 200NAMRHL205 | 200NAMRHL205 | 200NAMRHL205 |
| [ | 215MYACRD220 | 215 | 215 |
Figure 3Molecular modelling of BRA1 and BRA2 p26 using a p26 crystallographic structure (PDB code 1EIA) with Modeller software. Epitopes with amino acid alterations were compared in both models, showing surface residue alterations. Blue arrows point to amino acid alteration compared to the reference.